Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,54 USD | +1,72% | +14,19% | -19,55% |
Métier
Nombre d'employés: 17
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Brady
CEO | Chief Executive Officer | 54 | 01/09/19 |
Nicholas Maestas
DFI | Director of Finance/CFO | 44 | 12/07/21 |
Darrin Bomba
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/21 |
Sam Whiting
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/20 |
Comptroller/Controller/Auditor | 36 | 01/06/22 | |
Sharon Sakai
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 56 | 01/07/21 | |
Geoffrey Nichol
BRD | Director/Board Member | 69 | 01/12/19 |
Mike Raab Raab
CHM | Chairman | 59 | 01/01/21 |
Ronit Simantov
BRD | Director/Board Member | 59 | 06/08/21 |
Stephen Brady
CEO | Chief Executive Officer | 54 | 01/09/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 22 217 265 | 22 203 364 ( 99,94 %) | 0 | 99,94 % |
Coordonnées société
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway Suite 400
94005, Brisbane
+
http://www.tempesttx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-19,55% | 78,65 M | |
+1,51% | 42,75 Md | |
+8,57% | 41,34 Md | |
+49,22% | 41,61 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |
- Bourse
- Actions
- Action TPST
- Société Tempest Therapeutics, Inc.